Literature DB >> 10887515

The prolactin/growth hormone receptor family: structure/function relationships.

V Goffin1, P A Kelly.   

Abstract

Prolactin (PRL) and growth hormone (GH) receptors are members of the cytokine receptor superfamily that are activated by ligand-induced homodimerization. On the basis of this mechanism of activation, hormone antagonists have been developed that block the receptors in an inactive conformation. PRL and GH receptors are non-kinase receptors whose activation of signaling pathways requires participation of receptor-associated kinases, such as Janus kinases or Src kinases. Signal transduction by these receptors mainly involves the JAK/Stat pathway. In this review, we discuss the mechanism of ligand binding and receptor homodimerization as well as the involvement of molecules transducing the hormonal signal. Whenever possible, we attempt to correlate cytoplasmic features of the receptors with association and/or activation of transducer molecules or with a given biological property.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 10887515     DOI: 10.1023/a:1026313211704

Source DB:  PubMed          Journal:  J Mammary Gland Biol Neoplasia        ISSN: 1083-3021            Impact factor:   2.673


  60 in total

Review 1.  The prolactin/growth hormone receptor family.

Authors:  P A Kelly; J Djiane; M C Postel-Vinay; M Edery
Journal:  Endocr Rev       Date:  1991-08       Impact factor: 19.871

Review 2.  Cytokine receptor signalling through two novel families of transducer molecules: Janus kinases, and signal transducers and activators of transcription.

Authors:  J Finidori; P A Kelly
Journal:  J Endocrinol       Date:  1995-10       Impact factor: 4.286

3.  The SH2 domains of Stat1 and Stat2 mediate multiple interactions in the transduction of IFN-alpha signals.

Authors:  S Gupta; H Yan; L H Wong; S Ralph; J Krolewski; C Schindler
Journal:  EMBO J       Date:  1996-03-01       Impact factor: 11.598

Review 4.  STATs: signal transducers and activators of transcription.

Authors:  J N Ihle
Journal:  Cell       Date:  1996-02-09       Impact factor: 41.582

5.  Growth hormone binding protein--errant receptor or active player?

Authors:  G Baumann
Journal:  Endocrinology       Date:  1995-02       Impact factor: 4.736

6.  Development of a constitutively active mutant form of the prolactin receptor, a member of the cytokine receptor family.

Authors:  I Gourdou; L Gabou; J Paly; A Y Kermabon; L Belair; J Djiane
Journal:  Mol Endocrinol       Date:  1996-01

7.  Prolactin receptor is associated with c-src kinase in rat liver.

Authors:  J J Berlanga; J A Fresno Vara; J Martín-Pérez; J P García-Ruiz
Journal:  Mol Endocrinol       Date:  1995-11

8.  A single phosphotyrosine residue of the prolactin receptor is responsible for activation of gene transcription.

Authors:  J J Lebrun; S Ali; V Goffin; A Ullrich; P A Kelly
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-25       Impact factor: 11.205

9.  Roles of extracellular and cytoplasmic domains of the prolactin receptor in signal transduction to milk protein genes.

Authors:  L Lesueur; M Edery; J Paly; P A Kelly; J Djiane
Journal:  Mol Endocrinol       Date:  1993-09

10.  Identification of JAK protein tyrosine kinases as signaling molecules for prolactin. Functional analysis of prolactin receptor and prolactin-erythropoietin receptor chimera expressed in lymphoid cells.

Authors:  I Dusanter-Fourt; O Muller; A Ziemiecki; P Mayeux; B Drucker; J Djiane; A Wilks; A G Harpur; S Fischer; S Gisselbrecht
Journal:  EMBO J       Date:  1994-06-01       Impact factor: 11.598

View more
  35 in total

Review 1.  Transferrin and prolactin transcytosis in the lactating mammary epithelial cell.

Authors:  M Ollivier-Bousquet
Journal:  J Mammary Gland Biol Neoplasia       Date:  1998-07       Impact factor: 2.673

Review 2.  Developing a mammary gland is a stat affair.

Authors:  L Hennighausen; G W Robinson; K U Wagner; X Liu
Journal:  J Mammary Gland Biol Neoplasia       Date:  1997-10       Impact factor: 2.673

Review 3.  Mammary gland development in prolactin receptor knockout mice.

Authors:  C J Ormandy; N Binart; P A Kelly
Journal:  J Mammary Gland Biol Neoplasia       Date:  1997-10       Impact factor: 2.673

Review 4.  Prolactin function and putative expression in the brain.

Authors:  Erika Alejandra Cabrera-Reyes; Ofelia Limón-Morales; Nadia Alejandra Rivero-Segura; Ignacio Camacho-Arroyo; Marco Cerbón
Journal:  Endocrine       Date:  2017-06-20       Impact factor: 3.633

Review 5.  JAK-STAT pathway in carcinogenesis: is it relevant to cholangiocarcinoma progression?

Authors:  Olga V Smirnova; Tatiana Yu Ostroukhova; Roman L Bogorad
Journal:  World J Gastroenterol       Date:  2007-12-28       Impact factor: 5.742

Review 6.  Prolactin and mammary gland development.

Authors:  N D Horseman
Journal:  J Mammary Gland Biol Neoplasia       Date:  1999-01       Impact factor: 2.673

7.  Rapid Communication: Prolactin and hydrocortisone impact TNFα-mediated mitogen-activated protein kinase signaling and inflammation of bovine mammary epithelial (MAC-T) cells.

Authors:  L G Silva; B S Ferguson; A P Faciola
Journal:  J Anim Sci       Date:  2017-12       Impact factor: 3.159

8.  Medaka receptors for somatolactin and growth hormone: phylogenetic paradox among fish growth hormone receptors.

Authors:  Shoji Fukamachi; Takashi Yada; Hiroshi Mitani
Journal:  Genetics       Date:  2005-09-02       Impact factor: 4.562

9.  Prolactin stimulates cell proliferation through a long form of prolactin receptor and K+ channel activation.

Authors:  Fabien Van Coppenolle; Roman Skryma; Halima Ouadid-Ahidouch; Christian Slomianny; Morad Roudbaraki; Philippe Delcourt; Etienne Dewailly; Sandrine Humez; Alexandre Crépin; Isabelle Gourdou; Jean Djiane; Jean-Louis Bonnal; Brigitte Mauroy; Natalia Prevarskaya
Journal:  Biochem J       Date:  2004-02-01       Impact factor: 3.857

Review 10.  Prolactin regulation of mammary gland development.

Authors:  Samantha R Oakes; Renee L Rogers; Matthew J Naylor; Christopher J Ormandy
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-01-25       Impact factor: 2.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.